Sort   by:  
 Page size 
UnknownA polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials.
Not available
S-EPMC11980190 | biostudies-literature
UnknownSafety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Not available
S-EPMC7529856 | biostudies-literature
UnknownSafety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
Not available
S-EPMC10202119 | biostudies-literature
Sort   by:  
 Page size